Drugs / Emdogain
last change Mar 2026 re-read 9 days ago

Emdogain

also known as EMD

Other / unclassified

Developed for
gingival recession · periodontitis · periodontitis, aggressive
Investigated by
Rio de Janeiro State University · University of Louisville

Trials 2

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 42 trials
Phase 4 NCT05565079 Oct 2022 → Oct 2024 gingival recession University of Louisville Completed No outcome recorded
Phase 4 NCT03059966 Mar 2014 → Dec 2016 gingival recession Rio de Janeiro State University Completed No outcome recorded
Comparator or background therapy5 trials
Phase 4 NCT06250088 Comparator Mar 2024 → Jun 2025 — Universidad Complutense de Madrid Unknown No outcome recorded
Phase 4 NCT01030666 Background Apr 2007 → Jan 2011 periodontitis Peter Eickholz Terminated Missed primary
— NCT07292870 Comparator Aug 2025 → Dec 2027 expected periodontitis, aggressive Universitaire Ziekenhuizen KU Leuven Recruiting No outcome recorded
— NCT07230522 Comparator Mar → Jul 2024 periodontitis Medical University of Sofia Completed No outcome recorded
— NCT07841301 Comparator Dec 2021 → May 2023 periodontal disorder Medical University of Sofia Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Emdogain “12 patients will receive a coronally positioned tunnel with a regenerative tissue matrix (AlloDerm RTM, BioHorizons) and a porcine derived enamel matrix derivative (Emdogain,...” NCT05565079 ↗
6

“Evaluation of the Inflammatory and Healing Profile After Root Coverage With Emdogain®” NCT03059966 ↗

NCT07841301 ↗

NCT07292870 ↗

NCT07230522 ↗

NCT01030666 ↗

NCT06250088 ↗

Known as EMD “Periodontal Surgery Infrabony defects reported in this analysis are treated by application of EMD (Emdogain®, Institut Straumann AG, Basel, Switzerland).” NCT01030666 ↗
1

“Emdogain (EMD) - test” NCT06250088 ↗

Modality Other / unclassified “enamel matrix derivatives” NCT06250088 ↗
Route Topical “Enamel matrix derivative (Emdogain®) was then immediately applied, starting from the most distant part of the furcation defect and covering the entire exposed root surface.” NCT07841301 ↗